ACADEMY CAPITAL MANAGEMENT INC/TX - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 4 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADEMY CAPITAL MANAGEMENT INC/TX ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q3 2023$1,690
-25.3%
20,0000.0%0.00%
Q2 2023$2,261
+75266.7%
20,0000.0%0.00%
-100.0%
Q1 2023$3
-99.9%
20,0000.0%0.00%
Q4 2022$2,166
+116.6%
20,0000.0%0.00%
Q3 2022$1,0000.0%20,0000.0%0.00%
Q2 2022$1,0000.0%20,0000.0%0.00%
Q1 2022$1,0000.0%20,0000.0%0.00%
Q4 2021$1,0000.0%20,0000.0%0.00%
Q3 2021$1,0000.0%20,0000.0%0.00%
Q2 2021$1,0000.0%20,0000.0%0.00%
Q1 2021$1,0000.0%20,0000.0%0.00%
Q4 2020$1,0000.0%20,0000.0%0.00%
Q3 2020$1,0000.0%20,0000.0%0.00%
Q1 2020$1,0000.0%20,0000.0%0.00%
Q4 2019$1,0000.0%20,0000.0%0.00%
Q3 2019$1,0000.0%20,0000.0%0.00%
Q2 2019$1,0000.0%20,0000.0%0.00%
Q1 2019$1,0000.0%20,0000.0%0.00%
Q4 2018$1,0000.0%20,0000.0%0.00%
Q3 2018$1,0000.0%20,0000.0%0.00%
Q1 2018$1,0000.0%20,0000.0%0.00%
Q4 2017$1,00020,0000.0%0.00%
Q3 2017$0
-100.0%
20,0000.0%0.00%
Q3 2016$1,000
-83.3%
20,0000.0%0.00%
-100.0%
Q2 2016$6,000
-14.3%
20,0000.0%0.00%0.0%
Q1 2016$7,000
-58.8%
20,0000.0%0.00%
-33.3%
Q2 2014$17,000
-65.3%
20,0000.0%0.00%
-70.0%
Q1 2014$49,00020,0000.01%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q1 2019
NameSharesValueWeighting ↓
HOME FEDERAL BANK OF TENNESSEE 100,000$8,5000.00%
LEE DANNER & BASS INC 50,000$40.00%
LBMC INVESTMENT ADVISORS, LLC 22,000$1,7160.00%
Atlas Wealth LLC 26,620$2,2490.00%
ACADEMY CAPITAL MANAGEMENT INC/TX 20,000$1,6900.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders